| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Zoledronic Acid | FAERS: 24 | OFFSIDES US FAERS | |
| 2 | Lenalidomide | FAERS: 4 | US FAERS | |
| 3 | Pamidronate | FAERS: 2 | US FAERS | |
| 4 | tegaserod | FAERS: 2 | OFFSIDES US FAERS | |
| 5 | Aspirin | FAERS: 1 | US FAERS | |
| 6 | Carvedilol | FAERS: 1 | US FAERS | |
| 7 | Cytarabine | FAERS: 1 | US FAERS | |
| 8 | Fentanyl | FAERS: 1 | US FAERS | |
| 9 | Finasteride | FAERS: 1 | US FAERS | |
| 10 | Isotretinoin | FAERS: 1 | US FAERS | |
| 11 | Lidocaine | FAERS: 1 | US FAERS | |
| 12 | Mycophenolic Acid | FAERS: 1 | US FAERS | |
| 13 | Sevelamer | FAERS: 1 | US FAERS | |
| 14 | Sorafenib | FAERS: 1 | US FAERS | |
| 15 | Tacrolimus | FAERS: 1 | US FAERS | |
| 16 | Warfarin | FAERS: 1 | US FAERS | |
| 17 | niraparib | FAERS: 1 | US FAERS | |
| 18 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | Canada Vigilance: 1 | Canada Vigilance | |
| 19 | Anastrozole | OFFSIDES | ||
| 20 | Budesonide | OFFSIDES | ||
| 21 | Erythromycin | OFFSIDES | ||
| 22 | Estramustine | OFFSIDES | ||
| 23 | Goserelin | OFFSIDES | ||
| 24 | Ibandronic Acid | OFFSIDES | ||
| 25 | Imiquimod | OFFSIDES | ||
| 26 | Ketorolac Tromethamine | OFFSIDES | ||
| 27 | Medroxyprogesterone Acetate | OFFSIDES | ||
| 28 | Medroxyprogesterone | OFFSIDES | ||
| 29 | Melphalan | OFFSIDES | ||
| 30 | Methyltestosterone | OFFSIDES | ||
| 31 | Norethindrone Acetate | OFFSIDES | ||
| 32 | Norethindrone | OFFSIDES | ||
| 33 | Orphenadrine | OFFSIDES | ||
| 34 | Pamidronate | OFFSIDES | ||
| 35 | Tamoxifen | OFFSIDES | ||
| 36 | exemestane | OFFSIDES | ||
| 37 | tegaserod | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.